Repeated use of postcoital hormonal contraception for prevention of pregnancy

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2009, Pages

  Halpern, Vera ^a   Raymond, Elizabeth G ^a   Lopez, Laureen M ^a  

^a Behavioral and Social Science Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POSTCOITUS CONTRACEPTIVE AGENT;

ADVERSE OUTCOME; DRUG EFFICACY; DRUG SAFETY; EMERGENCY CONTRACEPTION; HORMONAL CONTRACEPTION; HUMAN; PREGNANCY; REVIEW; VAGINA BLEEDING;

EID: 70249102740     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007595     Document Type: Review

References (15)

1. Emergency Contraception. ACOG Practice Bulletin 2005.
2. Arowojolua AO, Adekunle AO. Perception and Practice of Emergency Contraception by Post-Secondary School Students in Southwest Nigeria. African Journal of Reproductive Health 2000;4:56-65.
3. Cheng L, Gülmezoglu AM, Piaggio G, Ezcurra E, Van Look PF. Interventions for emergency contraception. CochraneDatabase Syst Rev 2008;2:CD001324.
4. Croxatto HB, Ortiz ME, Muller AL. Mechanism of action of emergency contraception. Steroids 2003;68:1095-1098.
5. Farkas M, Apro G, Sas M. Clinico-pharmacological examination of Postinor. Ther Hung 1981;29:22-30.
6. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 5.0.0 [updated February 2008]. www.cochrane.dk/cochrane/ handbook/hbook.htm (accessed 24 October 2008).
7. Integrated Summary of Efficacy (ISE). Plan B® (levonorgestrel) for emergency contraception: Rx-to-OTC switch (supplement to NDA 21-045). http://www.fda.gov/OHRMS/DOCKETS/AC/03/briefing/4015B1-12-FDA-Tab%205-1- Medical%20Officer%20Review.doc 2003.
8. Integrated Summary of Safety (ISS). Plan B® (levonorgestrel) for emergency contraception: Rx-to-OTC switch (supplement to NDA 21-045). www.fda.gov/OHRMS/DOCKETS/AC/03/briefing/4015B1-12-FDA-Tab%205-1- Medical%20Officer%20Review.doc 2003.
9. Lerkiatbundit S, Reanmongkol W. Use of 0.75mg Levonorgestrel for postcoital contraception in Thailand. Journal of Clinical Pharmacy and Therapeutics 2000;25:185-190. (Pubitemid 30495310)
10. US National Institutes of Health (NIH). ClinicalTrials.gov. http://clinicaltrials.gov/ct2/home (accessed 20 June 2008). http:// clinicaltrials.gov/ct2/home.
11. Novikova N, Weisberg E, Stanczyk FZ, Croxatto HB, Fraser IS. Effectiveness of levonorgestrel emergency contraception given before or after ovulation - a pilot study. Contraception 2007;75:112-118. (Pubitemid 46127667)
12. Seregely G, Vero T. Postcoital contraception with 0.75 mg d-Norgestrel (Postinor). Magyar Noorvosok Lapia 1977;40:31-34.
13. Bhattacharjee SK, Romeo J, Kononova ES, Pretnar-Darovec A, Saraya L, Shi YE, Prasad RN, Bártfai G, Boukhris R, Van Look PF, et al.Postcoital contraception with levonorgestrel during the peri-ovulatory phase of the menstrual cycle. Task Force on Post-ovulatory Methods for Fertility Regulation. Contraception 1987;36:275-286.
14. No authors listed. Efficacy and side effects of immediate postcoital levonorgestrel used repeatedly for contraception. United Nations Development Programme/ United Nations Population Fund/World Health Organization/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Post-Ovulatory Methods of Fertility Regulation.. Contraception 2000;61:303-308.
15. World Health Organization (WHO). International Clinical Trials Registry Platform (ICTRP). http://www.who.int/ictrp/search/en/ (accessed 20 June 2008). http://www.who.int/ictrp/search/en.